Composition
- Active ingredients
- DELAFLOXACIN MEGLUMINE EQ 300MG BASE/VIAL
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- DELAFLOXACIN MEGLUMINE EQ 450MG BASE · TabletNDA208610-001 · Prescription
- DELAFLOXACIN MEGLUMINE EQ 300MG BASE/VIAL · PowderThis page
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA208611.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Baxdela
- Active substance
- delafloxacin meglumine
- Route
- Intravenous
- Dosage form
- Powder
- Applicant
- Melinta
- Status
- Prescription
- FDA approval
- 19 Jun 2017
- Application
- NDA208611-001